Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Catherine Faulkes"'
Autor:
Silvana Di Palma, Panagiotis Koliou, Alex Simonovic, Daniela Costa, Catherine Faulkes, Brenda Kobutungi, Felicity Paterson, Jonathan David Horsnell, Farrokh Pakzad, Tracey Irvine, Polly Partlett, Elizabeth Clayton, Nadine Collins
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2616 (2024)
The APIS Breast Cancer Subtyping Kit is an mRNA-based assessment of the seven parameters including three biomarkers routinely assessed in all the newly diagnosed breast cancers (BC), oestrogen receptor (ER), progesterone receptor (PR) and HER-2 and a
Externí odkaz:
https://doaj.org/article/0c12f12b824140a3a119b7103e410245
Autor:
Fiona Campbell, John M. Morgan, Elaine W. Kay, Keith Miller, Anthony O'Grady, Nadine Collins, Catherine Faulkes, J.M.S. Bartlett, Merdol Ibrahim, Bharat Jasani, Jane Starczynski
Publikováno v:
American Journal of Clinical Pathology. 135:157-162
We performed a multicenter assessment of a new HER2 dual-color chromogenic in situ hybridization (CISH) test and herein report on concordance of CISH data with fluorescence in situ hybridization (FISH) data and intraobserver and interlaboratory scori
Autor:
Claire Faulkner, Louise Lavender, Tina Bedenham, Ian A. Cree, Hongxiang Liu, Yuanxue Huang, Stacey Sandell, Charlene Crosby, Emma Howard, Julia Knight, John Goodall, Maggie Williams, Andrew L. Wallace, Antonio Milano, Martina Owens, Laura Dutton, Treena Cranston, Sian Ellard, Idowu Adebiyi, L. P. Lazarou, Alison Skinner, Elizabeth Young, Jonathan L A Callaway, Rachel Butler, Catherine Faulkes, Debbie Mair, Jonathan Mark Frampton, Vicky Spivey
Publikováno v:
Diagnostic molecular pathology : the American journal of surgical pathology, part B. 22(4)
EGFR mutation testing of tumor samples is routinely performed to predict sensitivity to treatment with tyrosine kinase inhibitors for patients with non-small cell lung cancer. At least 9 different methodologies are employed in UK laboratories, and th